NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules
NORML
APRIL 8, 2020
Under existing regulations, the agency only licenses one facility — the University of Mississippi — to cultivate cannabis for use in FDA-approved clinical trials. ” Specifically, the newly proposed rules expand the DEA’s authority by declaring it to be the only entity legally permitted to purchase, warehouse, and dispense any cannabis grown under a federal license. 2020 ACTIVISM GOVERNMENT Research SCIENCE Cultivation DEA University of Mississippi
Let's personalize your content